These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2110091)

  • 21. Expression and immunological properties of the five subunits of pertussis toxin.
    Nicosia A; Bartoloni A; Perugini M; Rappuoli R
    Infect Immun; 1987 Apr; 55(4):963-7. PubMed ID: 3549567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of complete and truncated forms of pertussis toxin subunits S1 and S2 synthesized by Escherichia coli.
    Locht C; Cieplak W; Marchitto KS; Sato H; Keith JM
    Infect Immun; 1987 Nov; 55(11):2546-53. PubMed ID: 3117686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The crystal structure of pertussis toxin.
    Stein PE; Boodhoo A; Armstrong GD; Cockle SA; Klein MH; Read RJ
    Structure; 1994 Jan; 2(1):45-57. PubMed ID: 8075982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter of the pertussis toxin operon and production of pertussis toxin.
    Nicosia A; Rappuoli R
    J Bacteriol; 1987 Jun; 169(6):2843-6. PubMed ID: 2438270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic exchange of the S2 and S3 subunits in pertussis toxin.
    Raze D; Veithen A; Sato H; Antoine R; Menozzi FD; Locht C
    Mol Microbiol; 2006 Jun; 60(5):1241-50. PubMed ID: 16689799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfer of a pertussis toxin expression locus to isogenic bvg-positive and bvg-negative strains of Bordetella bronchiseptica using an in vivo technique.
    Smith AM; Walker MJ
    Microb Pathog; 1996 May; 20(5):263-73. PubMed ID: 8861392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope.
    Burnette WN; Cieplak W; Mar VL; Kaljot KT; Sato H; Keith JM
    Science; 1988 Oct; 242(4875):72-4. PubMed ID: 2459776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of human T-cell epitopes on the S4 subunit of pertussis toxin.
    Petersen JW; Holm A; Ibsen PH; Hasløv K; Capiau C; Heron I
    Infect Immun; 1992 Oct; 60(10):3962-70. PubMed ID: 1383145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of pertussis toxin.
    Gross R; Aricò B; Rappuoli R
    Mol Microbiol; 1989 Jan; 3(1):119-24. PubMed ID: 2654538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of subunits of pertussis toxin in Tn5-induced Bordetella mutants deficient in toxin biological activity.
    Marchitto KS; Munoz JJ; Keith JM
    Infect Immun; 1987 May; 55(5):1309-13. PubMed ID: 2883124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages.
    van't Wout J; Burnette WN; Mar VL; Rozdzinski E; Wright SD; Tuomanen EI
    Infect Immun; 1992 Aug; 60(8):3303-8. PubMed ID: 1353482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and secretion of beta-glucuronidase and Pertussis toxin S1 by Streptomyces lividans.
    Paradis FW; Shareck F; Dupont C; Kluepfel D; Morosoli R
    Appl Microbiol Biotechnol; 1996 Jun; 45(5):646-51. PubMed ID: 8766700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A quantitative analysis for the ADP-ribosylation activity of pertussis toxin: an enzymatic-HPLC coupled assay applicable to formulated whole cell and acellular pertussis vaccine products.
    Cyr T; Menzies AJ; Calver J; Whitehouse LW
    Biologicals; 2001 Jun; 29(2):81-95. PubMed ID: 11580213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of pertussis toxin B oligomer assembled in vitro from recombinant polypeptides produced by Escherichia coli.
    Burnette WN; Arciniega JL; Mar VL; Burns DL
    Infect Immun; 1992 Jun; 60(6):2252-6. PubMed ID: 1587592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective immunogenicity of synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.
    Askelöf P; Rodmalm K; Wrangsell G; Larsson U; Svenson SB; Cowell JL; Undén A; Bartfai T
    Dev Biol Stand; 1991; 73():111-20. PubMed ID: 1778305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular aspects of Bordetella pertussis pathogenesis.
    Locht C
    Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation analysis of pertussis toxin promoter.
    Wo YY; Chiu SC; Lu CH
    J Microbiol Immunol Infect; 1999 Sep; 32(3):163-72. PubMed ID: 10637714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis.
    Stenson TH; Weiss AA
    Infect Immun; 2002 May; 70(5):2297-303. PubMed ID: 11953363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cellular and acellular anti-pertussis vaccines].
    Locht C
    Ann Pharm Fr; 2001 May; 59(3):198-205. PubMed ID: 11427821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of a pertussis toxin-sugar complex as a model for receptor binding.
    Stein PE; Boodhoo A; Armstrong GD; Heerze LD; Cockle SA; Klein MH; Read RJ
    Nat Struct Biol; 1994 Sep; 1(9):591-6. PubMed ID: 7634099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.